SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-029489
Filing Date
2022-11-10
Accepted
2022-11-10 16:14:37
Documents
16
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20221110.htm   iXBRL 8-K 33328
2 EX-99.1 exhibit991_111022pressrele.htm EX-99.1 23672
6 GRAPHIC image1a.jpg GRAPHIC 61583
7 GRAPHIC imagea.jpg GRAPHIC 87214
8 GRAPHIC logo.jpg GRAPHIC 9327
  Complete submission text file 0001628280-22-029489.txt   416635

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20221110.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20221110_lab.xml EX-101.LAB 23924
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20221110_pre.xml EX-101.PRE 12598
10 EXTRACTED XBRL INSTANCE DOCUMENT advm-20221110_htm.xml XML 10546
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 221377348
SIC: 2836 Biological Products, (No Diagnostic Substances)